20.20NOK-0.49%Mkt Cap: 83.73M $P/E: 12.021d ago
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; m…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap83.73M $
Enterprise Value83.19M $
Revenue (TTM)42.02M $
Gross Profit21.68M $
Net Income (TTM)6.99M $
Revenue/Share0.9470 USD
Last Price20.20 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees74
CountryNO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.02
P/E (Forward)—
PEG—
EV/EBITDA8.01
EV/Revenue1.98
P/S1.99
P/B2.72
EPS (TTM)1.68
EPS (Forward)—
52W Range
19.4014% of range25.30
52W High25.30 NOK
52W Low19.40 NOK
Profitability
Gross Margin51.28%
Oper. Margin19.18%
EBITDA Margin24.71%
Profit Margin16.53%
ROE22.73%
ROA17.01%
Growth
Revenue Growth-2.50%
Earnings Growth-1.20%
Cash Flow & Leverage
Operating CF7.29M $
CapEx (TTM)1.56M $
FCF Margin3.68%
FCF Yield1.84%
Net Debt-544.70K $
Net Debt/EBITDA-0.05
Balance Sheet
Debt/Equity0.00
Current Ratio2.96
Quick Ratio1.83
Book Value/Sh7.415 NOK
Cash/Share0.1430 NOK
Dividends
Fwd Div Rate2.250 NOK
Trail. Div Rate1.500 NOK
Div. Yield11.08%
5Y Avg Yield—
Payout Ratio74.40%
Ex-Div DateMay 22, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.44.34M
Float21.97M
Insiders58.94%
Institutions13.74%
Technical
SMA 5021.05 (-4.0%)
SMA 20021.27 (-5.0%)
Beta0.61
S&P 52W Chg19.63%
Avg Vol (30d)31.02K
Avg Vol (10d)11.22K
Technical Indicators
RSI (14)41.1
MACD-0.1627
MACD Signal-0.1826
MACD Hist.+0.0199
BB Upper20.85 NOK
BB Middle20.50 NOK
BB Lower20.14 NOK
BB Width3.50%
ATR (14)0.3902 NOK
Vol Ratio (20d)3.88x